John Szilagyi (left) is a Principal Scientist at Bristol Myers Squibb (NJ, USA), working in nonclinical development and investigative toxicology, with a focus on the development of models to study ...

Advanced 3D cell models recreate the complexity of human tissues, enabling researchers to examine tumor progression, probe neurological disorders, and assess therapeutic candidates. By capturing the ...

Scientists have successfully immortalized lip cells, allowing new treatments for injuries and infections to be trialed on a clinically relevant lab-based model We use our lips to talk, eat, drink, and ...

Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

DUBLIN--(BUSINESS WIRE)--Inventia Life Science, a leading advanced cell model company, launched the Inventia Third Dimension Grant today. This grant will allow researchers studying fundamental biology ...

SYDNEY--(BUSINESS WIRE)--Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology ...

Advancing neurological disorder research requires model systems that more accurately reflect the human brain. 3D cell cultures, such as organoids and spheroids, have emerged as game-changers by better ...

In the new study, the team used the model to demonstrate that as Alzheimer's pathology accumulates in the brain, specific types of immune cells called CT8+ T Cells surge into the brain and amplify the ...

Researchers have designed lightweight and powerful fuel cells using 3D printing and a coral-inspired structure. Developed by ...

The majority of potential oncology drugs fail at some stage of the drug development pipeline, despite demonstrating promising in vitro efficacy data. This common phenomenon is driving the development ...